Centro Nacional de Investigaciones Oncológicas (Spanish National Cancer Research Centre)

• Faculty
• Scientific Programmes
• Annual Report
• Scientific Publications
• Research Projects
• International Affairs
• Animal Research

All Publications

Quick Search       Advanced Search

• Hernández-Vargas, H., Ballestar, E., Carmona, P., Von Kobbe, C., Banon-Rodríguez, I., Esteller, M., Moreno-Bueno, G., Palacios, J. (2006). Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: Relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. Int J Cancer 119, 1164-1175.
• Lawrie CH, Marafioti T, Hatton CS, Dirnhofer S, Roncador G, Went P, Tzankov A, Pileri SA, Pulford K, Banham AH (2006). Cancer-associated carbohydrate identification in Hodgkin's lymphotna by carbohydrate array profiling. Int J Cancer 118, 3161-3166.
• Steitz J, Büchs S, Tormo D, Ferrer A, Wenzel J, Huber C, Wölfel T, Barbacid M, Malumbres M, Tüting T (2006). Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin. Int J Cancer 118, 373-380.
• Tang, M., Torres-Lanzas, J., López-Rios, F., Esteller, M., Sanchez-Céspedes, M. (2006). Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lung. Int J Cancer 119, 2603-2609.
• Pinilla SM, Honrado E, Hardisson D, Benítez J, Palacios J (2006). Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat 99, 85-90.
• Sarrió D, Rodríguez-Pinilla SM, Dotor A, Calero F, Hardisson D, Palacios J (2006). Abnormal ezrin expresion is associated with clinicopathological features in breast cancer. Breast Cancer Res Treat 98, 1-79.
• Rinaldi A, Kwee I, Taborelli M, Largo C, Uccella S, Martin V, Poretti G, Gaidano G, Calabrese G, Martinelli G, Baldini L, Pruneri G, Capella C, Zucca E, Cotter FE, Cigudosa JC, Catapano CV, Tibiletti MG, Bertoni F (2006). Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br J Haematol 132, 303-316.
• Honrado E, Benítez J, Palacios J (2006). Histopathology of BRCA1- and BRCA2-associated breast cancer. Crit Rev Oncol Hematol 59, 27-39.
• Esteller, M. (2006). Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 94, 179-183.
• McGuire V, John EM, Felberg A, Haile RW, Boyd NF, Thomas DC, Jenkins MA, Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, Southey M, West DW, Hopper JL, Whittemore AS; kConFab Investigators (2006). No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years. Cancer Epidem Biomar 12, 6652-6662.